These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 32151670

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18.
    Layman H, Rickert KW, Wilson S, Aksyuk AA, Dunty JM, Natrakul D, Swaminathan N, DelNagro CJ.
    PLoS One; 2020; 15(3):e0229672. PubMed ID: 32214362
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
    Seo SH, Jin HT, Park SH, Youn JI, Sung YC.
    Vaccine; 2009 Sep 25; 27(42):5906-12. PubMed ID: 19651174
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
    Kenter GG, Welters MJ, Valentijn AR, Lowik MJ, Berends-van der Meer DM, Vloon AP, Drijfhout JW, Wafelman AR, Oostendorp J, Fleuren GJ, Offringa R, van der Burg SH, Melief CJ.
    Clin Cancer Res; 2008 Jan 01; 14(1):169-77. PubMed ID: 18172268
    [Abstract] [Full Text] [Related]

  • 13. Antibody response for L1, E6, E7 HPV 16, and HPV 18 antigens in Tunisian women with cervical cancer.
    Achour M, Zeghal D, Kochbati L, Kahla S, Zouari F, Maâlej M, Oueslati R.
    J Immunoassay Immunochem; 2009 Jan 01; 30(1):82-96. PubMed ID: 19117204
    [Abstract] [Full Text] [Related]

  • 14. Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial.
    Santin AD, Bellone S, Palmieri M, Zanolini A, Ravaggi A, Siegel ER, Roman JJ, Pecorelli S, Cannon MJ.
    J Virol; 2008 Feb 01; 82(4):1968-79. PubMed ID: 18057249
    [Abstract] [Full Text] [Related]

  • 15. Design and evaluation of a multi-epitope DNA vaccine against HPV16.
    Zhu L, Cui X, Yan Z, Tao Y, Shi L, Zhang X, Yao Y, Shi L.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2352908. PubMed ID: 38780076
    [Abstract] [Full Text] [Related]

  • 16. HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.
    van Poelgeest MI, Welters MJ, van Esch EM, Stynenbosch LF, Kerpershoek G, van Persijn van Meerten EL, van den Hende M, Löwik MJ, Berends-van der Meer DM, Fathers LM, Valentijn AR, Oostendorp J, Fleuren GJ, Melief CJ, Kenter GG, van der Burg SH.
    J Transl Med; 2013 Apr 04; 11():88. PubMed ID: 23557172
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antibody response for L1, E6 and E7 HPV 16 and HPV 18 antigens in Tunisian women with cervical cancer and controls.
    Achour M, Zeghal D, Kochbati L, Kahla S, Zouari F, Maalej M, Oueslati R.
    J Immunoassay Immunochem; 2008 Apr 04; 29(3):266-80. PubMed ID: 18569375
    [Abstract] [Full Text] [Related]

  • 19. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
    Rezhake R, Hu SY, Zhao S, Xu XQ, Zhao XL, Zhang L, Wang Y, Zhang X, Pan QJ, Qiao YL, Zhao FH.
    Int J Cancer; 2019 Jan 01; 144(1):34-42. PubMed ID: 29943809
    [Abstract] [Full Text] [Related]

  • 20. Vaccination of full-length HPV16 E6 or E7 protein inhibits the growth of HPV16 associated tumors.
    Li YL, Qiu XH, Shen C, Liu JN, Zhang J.
    Oncol Rep; 2010 Nov 01; 24(5):1323-9. PubMed ID: 20878127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.